Cargando…

Type of chemotherapy has substantial effects on the immune system in ovarian cancer

Chemotherapy induces a variety of immunological changes. Studying these effects can reveal opportunities for successful combining chemotherapy and immunotherapy. Immuno-chemotherapeutic combinations in ovarian cancer are currently not generating the anticipated positive effects. To date, only scatte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vankerckhoven, Ann, Baert, Thaïs, Riva, Matteo, De Bruyn, Christine, Thirion, Gitte, Vandenbrande, Katja, Ceusters, Jolien, Vergote, Ignace, Coosemans, An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022256/ https://www.ncbi.nlm.nih.gov/pubmed/33770618 http://dx.doi.org/10.1016/j.tranon.2021.101076

Ejemplares similares

Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer
por: De Bruyn, Christine, et al.
Publicado: (2021)

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer
por: Baert, Thaïs, et al.
Publicado: (2019)

Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study
por: Vankerckhoven, Ann, et al.
Publicado: (2020)

Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model
por: Wouters, Roxanne, et al.
Publicado: (2022)

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy
por: Berckmans, Yani, et al.
Publicado: (2023)

Intraperitoneal alpha therapy with (224)Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model
por: Wouters, Roxanne, et al.
Publicado: (2022)

Ovarian cancer and the immune system
por: Baert, Thaïs, et al.
Publicado: (2017)

The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer
por: Baert, Thaïs, et al.
Publicado: (2015)

A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?
por: Coosemans, A., et al.
Publicado: (2015)

Immunological parameters as a new lead in the diagnosis of ovarian cancer
por: Baert, T., et al.
Publicado: (2015)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer
por: Sprooten, Jenny, et al.
Publicado: (2021)

Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates
por: Berckmans, Yani, et al.
Publicado: (2023)

Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021)

Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study
por: Jansen, Jolien, et al.
Publicado: (2023)

Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study
por: Van Calster, Ben, et al.
Publicado: (2020)

CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression
por: Riva, Matteo, et al.
Publicado: (2019)

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer
por: Lambrechts, Sandrina, et al.
Publicado: (2015)

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
por: Dumont, Sander, et al.
Publicado: (2019)

Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis
por: Zahl, P-H, et al.
Publicado: (2013)

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification
por: Olbrecht, Siel, et al.
Publicado: (2021)

The correlation between reading and mathematics ability at age twelve has a substantial genetic component
por: Davis, Oliver S. P., et al.
Publicado: (2014)

Substantial Achilles adaptation following strength training has no impact on tendon function during walking
por: Waugh, C. M., et al.
Publicado: (2021)

Multiclass risk models for ovarian malignancy: an illustration of prediction uncertainty due to the choice of algorithm
por: Ledger, Ashleigh, et al.
Publicado: (2023)

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer
por: Van Nieuwenhuysen, Els, et al.
Publicado: (2019)

Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy
por: Park, Anthony, et al.
Publicado: (2012)

Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN(®) in combination with chemotherapy
por: Kumar, Chaitanya, et al.
Publicado: (2019)

VX-765 has a Protective Effect on Mice with Ovarian Injury Caused by Chemotherapy
por: Lee, Pingyin, et al.
Publicado: (2023)

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU
por: Sussman, G., et al.
Publicado: (2018)

Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation
por: Gevaert, Olivier, et al.
Publicado: (2008)

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
por: Vanderstichele, Adriaan, et al.
Publicado: (2022)

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
por: Maenhoudt, Nina, et al.
Publicado: (2020)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma
por: Wouters, Roxanne, et al.
Publicado: (2020)

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
por: Mungenast, Felicitas, et al.
Publicado: (2017)

Substantiating efficacy of probiotics
por: Mercenier, Annick
Publicado: (2011)

Substantial Annual Distribution
Publicado: (1920)

Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience
por: Moubarak, Malak, et al.
Publicado: (2022)

Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type
por: Gaitskell, Kezia, et al.
Publicado: (2015)

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_scnk4ovp93phpianqd3775seb8